TRACON Pharmaceuticals, Inc. (TCON)
OTCMKTS
· Delayed Price · Currency is USD
0.0632
+0.0052 (8.97%)
Nov 14, 2024, 2:47 PM EST
TRACON Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 6.27 | 8.56 | 17.43 | 24.07 | 32.13 | 16.41 | Upgrade
|
| Short-Term Investments | - | - | - | - | 4 | - | Upgrade
|
| Cash & Short-Term Investments | 6.27 | 8.56 | 17.43 | 24.07 | 36.13 | 16.41 | Upgrade
|
| Cash Growth | 261.38% | -50.87% | -27.58% | -33.37% | 120.14% | -58.03% | Upgrade
|
| Prepaid Expenses | 0.24 | 0.53 | 0.8 | 0.86 | 0.78 | 0.85 | Upgrade
|
| Total Current Assets | 6.51 | 9.09 | 18.23 | 24.94 | 36.91 | 17.26 | Upgrade
|
| Property, Plant & Equipment | 0.82 | 0.94 | 1.17 | 1.38 | 0.52 | 0.86 | Upgrade
|
| Long-Term Investments | - | - | - | 0.25 | - | - | Upgrade
|
| Other Long-Term Assets | 0.07 | 0.07 | 0.07 | - | - | - | Upgrade
|
| Total Assets | 7.4 | 10.11 | 19.47 | 26.56 | 37.44 | 18.12 | Upgrade
|
| Accounts Payable | 2.65 | 2.54 | 3.92 | 4.94 | 1.73 | 2.41 | Upgrade
|
| Accrued Expenses | 6.94 | 7.4 | 8.44 | 7.2 | 5.68 | 6.47 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | 9.81 | 1.39 | 2.72 | 2.6 | Upgrade
|
| Current Portion of Leases | 0.3 | 0.24 | 0.2 | 0.15 | 0.42 | 0.36 | Upgrade
|
| Total Current Liabilities | 9.89 | 10.18 | 22.37 | 13.68 | 10.54 | 11.83 | Upgrade
|
| Long-Term Debt | - | - | - | - | 1.39 | 2.74 | Upgrade
|
| Long-Term Leases | 0.6 | 0.73 | 0.97 | 1.17 | 0.15 | 0.57 | Upgrade
|
| Other Long-Term Liabilities | - | - | 3.28 | - | 0.28 | 0.28 | Upgrade
|
| Total Liabilities | 10.49 | 10.91 | 26.62 | 14.84 | 12.37 | 15.42 | Upgrade
|
| Common Stock | 0 | 0.04 | 0.02 | 0.02 | 0.02 | 0 | Upgrade
|
| Additional Paid-In Capital | 243.41 | 239.65 | 229.74 | 219.47 | 204.17 | 165.03 | Upgrade
|
| Retained Earnings | -246.51 | -240.5 | -236.91 | -207.78 | -179.11 | -162.33 | Upgrade
|
| Total Common Equity | -3.09 | -0.81 | -7.15 | 11.71 | 25.07 | 2.7 | Upgrade
|
| Shareholders' Equity | -3.09 | -0.81 | -7.15 | 11.71 | 25.07 | 2.7 | Upgrade
|
| Total Liabilities & Equity | 7.4 | 10.11 | 19.47 | 26.56 | 37.44 | 18.12 | Upgrade
|
| Total Debt | 0.9 | 0.97 | 10.97 | 2.71 | 4.68 | 6.27 | Upgrade
|
| Net Cash (Debt) | 5.37 | 7.6 | 6.46 | 21.37 | 31.45 | 10.14 | Upgrade
|
| Net Cash Growth | 630.88% | 17.60% | -69.77% | -32.06% | 210.05% | -68.96% | Upgrade
|
| Net Cash Per Share | 2.36 | 4.64 | 6.18 | 24.77 | 70.01 | 66.86 | Upgrade
|
| Filing Date Shares Outstanding | 3.41 | 2.28 | 1.19 | 0.98 | 0.77 | 0.27 | Upgrade
|
| Total Common Shares Outstanding | 3.41 | 2.21 | 1.16 | 0.97 | 0.77 | 0.2 | Upgrade
|
| Working Capital | -3.38 | -1.09 | -4.14 | 11.26 | 26.37 | 5.43 | Upgrade
|
| Book Value Per Share | -0.91 | -0.37 | -6.18 | 12.05 | 32.40 | 13.32 | Upgrade
|
| Tangible Book Value | -3.09 | -0.81 | -7.15 | 11.71 | 25.07 | 2.7 | Upgrade
|
| Tangible Book Value Per Share | -0.91 | -0.37 | -6.18 | 12.05 | 32.40 | 13.32 | Upgrade
|
| Machinery | - | 0.22 | 0.22 | 0.21 | 0.16 | 0.15 | Upgrade
|
| Leasehold Improvements | - | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.